Where do we go from here? Relations between the medical profession and the pharmaceutical industry Joseph S. Alpert Editor’s Commentary Pages: 169 - 170
Familial cardiomyopathies: Significant causes of heart failure Kathy A. Crispell OriginalPaper Pages: 187 - 192
Sex differences in the causes and natural history of heart failure Bobbi L. HoppeDenise D. Hermann OriginalPaper Pages: 193 - 199
Matrix metalloproteinase in left ventricular remodeling and heart failure Suresh ShastryMelvin R. HaydenSuresh C. Tyagi OriginalPaper Pages: 200 - 204
The prognostic significance of renal dysfunction in patients with chronic systolic heart failure S. Raja LaskarDaniel L. Dries OriginalPaper Pages: 205 - 210
Management issues for patients with coronary artery disease and heart failure Andrew D. FeingoldDavid DeNofrio OriginalPaper Pages: 216 - 222
Management of heart failure in the elderly Roger KerznerMichael W. Rich OriginalPaper Pages: 223 - 228
New therapies for the management of acute heart failure Philip A. Poole-WilsonShu-Ren Xue OriginalPaper Pages: 229 - 236
The rational use of diuretics in heart failure Susan L. RavnanPrakash C. Deedwania OriginalPaper Pages: 237 - 242
Nonpharmacologic options for the management of heart failure Robin J. TruppWilliam T. Abraham OriginalPaper Pages: 243 - 246